Miss Dikshyanta Rana

  • Research Associate (Health Economics & Health Technology Assessment)

telephone: +44(0)141 330 6613
email: Dikshyanta.Rana@glasgow.ac.uk
pronouns: She/her/hers

Clarice Pears Building, Glasgow, G12 8TB

Import to contacts

ORCID iDhttps://orcid.org/0000-0001-9133-3094

Biography

Dikshyanta joined the Health Economics and Health Technology Assessment (HEHTA) team in 2018 after completing her MSc in Health Economics at the University of York. During her MSc, she did a placement at the Mental Health and Addiction Research Group (MHARG) within her university. She obtained an undergraduate degree in BA (Hons) Economics, with Psychology and Sociology as additional subjects, from Christ University, India in 2016. She has more than 6 years of experience working in this field.

Dikshyanta represents our early career researchers (ECRs) in the Scottish Health Economics Early Career (SHEEC) network.

Research interests

Dikshyanta is a mixed methods researcher with a broad range of experience in conducting economic evaluations, linked health data analysis, evidence synthesis, and thematic analysis. Her research focuses on the development and application of HTA methodologies across various health areas, including cardiovascular diseases, learning disabilities, oncology, mental health, and women's health.

Currently, she is primarily involved in the INCISE project, where she applies eHTA concepts and explores the field of precision medicine and translational health economics. 

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020
Number of items: 16.

2025

Rana, D. et al. (2025) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review. Health Technology Assessment, 29(4), (doi: 10.3310/BSTG4556) (PMID:40025754)

2024

Rana, D. et al. (2024) Lifestyle modification interventions for adults with intellectual disabilities: systematic review and meta-analysis at intervention and component levels. Journal of Intellectual Disability Research, 68(5), pp. 387-445. (doi: 10.1111/jir.13098) (PMID:38414293)

Westrop, S. C., Rana, D. , Jaiswal, N. , Wu, O. , Mcgarty, A. M. , Melville, C. , Ells, L., Lally, P., McEwan, M. and Germeni, E. (2024) Supporting active engagement of adults with intellectual disabilities in lifestyle modification interventions: A realist evidence synthesis of what works, for whom, in what context and why. Journal of Intellectual Disability Research, 68(4), pp. 293-316. (doi: 10.1111/jir.13120) (PMID:38379511)

2023

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

2022

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818) (PMCID:PMC9082260)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

2021

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. [Research Reports or Papers]

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

2020

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. [Research Reports or Papers]

This list was generated on Sun Apr 27 00:45:08 2025 BST.
Jump to: Articles | Research Reports or Papers | Conference or Workshop Item
Number of items: 16.

Articles

Rana, D. et al. (2025) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review. Health Technology Assessment, 29(4), (doi: 10.3310/BSTG4556) (PMID:40025754)

Rana, D. et al. (2024) Lifestyle modification interventions for adults with intellectual disabilities: systematic review and meta-analysis at intervention and component levels. Journal of Intellectual Disability Research, 68(5), pp. 387-445. (doi: 10.1111/jir.13098) (PMID:38414293)

Westrop, S. C., Rana, D. , Jaiswal, N. , Wu, O. , Mcgarty, A. M. , Melville, C. , Ells, L., Lally, P., McEwan, M. and Germeni, E. (2024) Supporting active engagement of adults with intellectual disabilities in lifestyle modification interventions: A realist evidence synthesis of what works, for whom, in what context and why. Journal of Intellectual Disability Research, 68(4), pp. 293-316. (doi: 10.1111/jir.13120) (PMID:38379511)

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

Daniels, J. et al. (2022) Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technology Assessment, 26(22), (doi: 10.3310/ZDEG6110) (PMID:35435818) (PMCID:PMC9082260)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

Rana, D. et al. (2021) Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1793-1802. (doi: 10.1111/1471-0528.16781) (PMID:34053154)

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Stock, S. J. et al. (2021) Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol. BMJ Open, 11(5), e050452. (doi: 10.1136/bmjopen-2021-050452) (PMID:33947741) (PMCID:33947741)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Rana, D. , Westrop, S., Germeni, E. , Mcgarty, A. , Ells, L., Lally, P., McEwan, M., Melville, C. , Harris, L. and Wu, O. (2021) Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: Protocol for a mixed-methods systematic review. Systematic Reviews, 10, 251. (doi: 10.1186/s13643-021-01808-0) (PMID:34544482) (PMCID:PMC8453997)

Robles-Zurita, J. A., Briggs, A. , Rana, D. , Quayyum, Z., Oldroyd, K. G., Zeymer, U., Desch, S., de Waha-Thiele, S. and Thiele, H. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. European Journal of Health Economics, 21, pp. 1197-1209. (doi: 10.1007/s10198-020-01235-3) (PMID:33029668)

Research Reports or Papers

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. [Research Reports or Papers]

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. [Research Reports or Papers]

Conference or Workshop Item

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

This list was generated on Sun Apr 27 00:45:08 2025 BST.

Teaching

Dikshyanta is actively involved in a range of teaching activities within HEHTA.

She co-leads the Health Economics for HTA module in our online MSc HTA programme and lectures in the MSc Precision Medicine course. Additionally, she supervises students in the MSc HTA, Master of Public Health, and MSc Population Health Sciences programmes. She also tutors on our continuous professional development (CPD) courses.

Previously, Dikshyanta has contributed to the development and delivery of our Future Learn micro-credentials course, 'Introduction to Health Economics & Health Technology Assessment'. This course is now a part of our ExpertTrack course, Using Health Technology Assessment in support of Universal Health Coverage.
 
Moreover, she has also developed and delivered courses for the Better Health Programme (BHP) - Philippines, a project funded by the U.K. Foreign Commonwealth and Development Office Prosperity Fund in partnership with PricewaterhouseCoopers (PwC) and FHI 360.

Dikshyanta Rana

Miss Dikshyanta Rana on Twitter